How to Help Your Patients Save Money on Dextroamphetamine: A Provider's Guide to Savings Programs

Cost Is One of the Biggest Barriers to Medication Adherence

For patients prescribed Dextroamphetamine, cost can be the difference between filling a prescription and abandoning it. As a provider, you know that non-adherence due to cost is a widespread problem — and it's one that directly affects treatment outcomes for ADHD and narcolepsy.

The good news is that there are practical tools and programs that can significantly reduce what your patients pay. This guide walks through what patients are currently paying, available savings programs, and how to integrate cost conversations into your clinical workflow.

What Patients Are Paying for Dextroamphetamine in 2026

Dextroamphetamine costs vary dramatically depending on the formulation, brand vs. generic, and insurance status:

• Generic immediate-release (IR) tablets: $30–$80 per month at retail; approximately $37–$45 with discount coupons (GoodRx, SingleCare)
• Generic extended-release (ER) capsules: $50–$120 per month
• Brand-name Zenzedi (IR): $200–$400+ per month
• Brand-name Dexedrine Spansule (ER): Often $150–$300+ per month
• ProCentra oral solution: Varies widely; typically more expensive than tablets

Patients with commercial insurance typically have lower out-of-pocket costs for generics, but those on high-deductible plans, Medicare Part D (in the donut hole), or without insurance face the full retail price. Given the ongoing Dextroamphetamine shortage, some patients are forced to fill at whichever pharmacy has stock — even if it's not their usual (and cheapest) option.

Manufacturer Savings Programs

Manufacturer-sponsored savings programs are most relevant for brand-name prescriptions:

Zenzedi (Arbor Pharmaceuticals)

Arbor Pharmaceuticals has historically offered copay assistance for Zenzedi. Eligible patients with commercial insurance may receive significant discounts on their copay. The availability and terms of these programs change frequently, so direct patients to Zenzedi.com or have your office staff check current offers.

Important limitations:

• Manufacturer copay cards are not available to patients with government insurance (Medicare, Medicaid, Tricare, VA)
• Programs may have annual caps on savings
• Enrollment may require providing insurance information

Generic Dextroamphetamine

There are no manufacturer savings programs for generic Dextroamphetamine, as it's produced by multiple manufacturers. However, this is where discount cards and other programs become essential.

Coupon and Discount Cards

Prescription discount cards can substantially reduce out-of-pocket costs for generic Dextroamphetamine, particularly for uninsured and underinsured patients:

• GoodRx — Consistently shows prices of $37–$45 for a 30-day supply of generic IR tablets. Patients can access coupons at goodrx.com or through the GoodRx app. Prices vary by pharmacy.
• SingleCare — Comparable pricing to GoodRx. Available at singlecare.com.
• RxSaver — Another option at rxsaver.com with pharmacy price comparisons.
• Optum Perks — Formerly SearchRx. Available at perks.optum.com.
• BuzzRx, America's Pharmacy, Inside Rx — Additional discount card options worth checking for competitive pricing.

Provider tip: Consider keeping a simple handout in your office listing these coupon card options. Many patients don't know they exist, and a 30-second conversation can save them hundreds of dollars per year.

Note that discount cards cannot be combined with insurance. Patients should compare their insurance copay to the discount card price and use whichever is lower.

Patient Assistance Programs

For patients facing financial hardship, several resources can help:

• NeedyMeds (needymeds.org) — A database of patient assistance programs, discount cards, and other resources searchable by drug name.
• RxAssist (rxassist.org) — Another comprehensive directory of assistance programs.
• State pharmaceutical assistance programs (SPAPs) — Many states offer programs for low-income residents who need help affording medications. Eligibility varies by state.
• Nonprofit assistance — Organizations focused on ADHD (like CHADD) may have resources or can point patients toward local assistance programs.

There is no major standalone patient assistance program for generic Dextroamphetamine, but the resources above can help patients find available support.

Generic Alternatives and Therapeutic Substitution

If cost is a barrier, consider these strategies:

Ensure the Patient Is on Generic

If a patient is taking brand-name Zenzedi ($200–$400+/month) and the brand is not medically necessary, switching to generic Dextroamphetamine IR ($37–$45/month with coupons) provides identical active ingredients at a fraction of the cost.

Therapeutic Alternatives

If generic Dextroamphetamine remains too expensive or unavailable due to the shortage, consider therapeutic alternatives:

• Mixed Amphetamine Salts (generic Adderall) — Often similarly priced or cheaper, and more widely available during the current shortage. Contains 75% Dextroamphetamine and 25% Levoamphetamine.
• Methylphenidate (generic Ritalin or Concerta) — A different stimulant class that may be more accessible and affordable. Generic IR Methylphenidate is typically $15–$40/month.
• Lisdexamfetamine (Vyvanse) — A prodrug of Dextroamphetamine. Brand-name only until recently, but generic Lisdexamfetamine became available in 2023, which has brought costs down. Check current pricing.
• Atomoxetine (generic Strattera) — A non-stimulant option. Not as effective for most ADHD patients, but it's not a controlled substance and avoids the shortage issues affecting stimulants.

For a detailed comparison, see our guide to Dextroamphetamine alternatives.

Formulation Considerations

IR tablets are generally cheaper than ER capsules and the oral solution. If a patient can manage multiple daily doses, IR may be the most cost-effective option. Conversely, patients who struggle with adherence on a multi-dose IR regimen may benefit from ER despite the higher cost — poor adherence is ultimately the most expensive outcome.

Building Cost Conversations Into Your Workflow

Research consistently shows that patients hesitate to bring up cost concerns, and providers often don't ask. Here are practical ways to make cost a standard part of your clinical workflow:

1. Ask About Cost at Every Prescribing Decision

A simple question — "Is cost a concern for you with this medication?" — opens the door. Many patients will say yes, and that's your opportunity to discuss generics, coupons, or alternatives.

2. Keep a Cost Resource Sheet

Create a one-page handout for your office that lists:

• Top discount card websites (GoodRx, SingleCare, RxSaver)
• Patient assistance program links (NeedyMeds, RxAssist)
• A note about comparing insurance copay vs. discount card price
• A link to Medfinder for Providers for stock availability

3. Check Availability Before Prescribing

Given the ongoing Dextroamphetamine shortage, it's worth checking whether a specific strength and formulation is available before sending a prescription. Medfinder can help you and your staff quickly verify pharmacy stock, reducing the frustration of patients being turned away at the counter.

4. Document Cost Barriers

If a patient reports cost as a barrier to adherence, document it in the chart. This creates a record for future visits, supports prior authorization appeals, and can justify therapeutic substitutions to insurance companies.

5. Revisit Cost Annually

Insurance plans change every year. A medication that was affordable last year may not be this year. Make it a habit to ask about medication costs at annual checkups or when renewing ongoing prescriptions.

Final Thoughts

Medication cost is a clinical issue, not just a financial one. When patients can't afford Dextroamphetamine, they stop taking it — and their ADHD or narcolepsy symptoms return, affecting their work, relationships, and quality of life. By building cost awareness into your prescribing workflow, you can improve adherence, reduce patient frustration, and deliver better outcomes.

For real-time pharmacy stock information and provider tools, visit Medfinder for Providers. For help navigating the current shortage, see our provider's guide to finding Dextroamphetamine in stock.